Hedge Funds Are Selling BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) was in 24 hedge funds’ portfolio at the end of December. BMRN investors should be aware of a decrease in support from the world’s most elite money managers in recent months. There were 33 hedge funds in our database with BMRN positions at the end of the previous quarter.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)If you’d ask most investors, hedge funds are assumed to be unimportant, old financial vehicles of the past. While there are greater than 8000 funds in operation today, we at Insider Monkey hone in on the bigwigs of this group, around 450 funds. It is estimated that this group controls the majority of the hedge fund industry’s total asset base, and by paying attention to their top stock picks, we have identified a number of investment strategies that have historically outperformed the broader indices. Our small-cap hedge fund strategy outstripped the S&P 500 index by 18 percentage points annually for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have trumped the S&P 500 index by 25 percentage points in 6.5 month (see all of our picks from August).

Just as beneficial, optimistic insider trading activity is another way to parse down the world of equities. Obviously, there are plenty of reasons for an insider to drop shares of his or her company, but only one, very simple reason why they would initiate a purchase. Many academic studies have demonstrated the valuable potential of this method if you know where to look (learn more here).

Consequently, we’re going to take a look at the recent action surrounding BioMarin Pharmaceutical Inc. (NASDAQ:BMRN).

What have hedge funds been doing with BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)?

In preparation for this year, a total of 24 of the hedge funds we track were bullish in this stock, a change of -27% from one quarter earlier. With hedgies’ positions undergoing their usual ebb and flow, there exists an “upper tier” of notable hedge fund managers who were boosting their stakes considerably.

When looking at the hedgies we track, Steven Cohen’s SAC Capital Advisors had the largest position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), worth close to $119 million, accounting for 0.6% of its total 13F portfolio. Sitting at the No. 2 spot is Jérôme Pfund and Michael Sjöström of Sectoral Asset Management, with a $104 million position; 0.1% of its 13F portfolio is allocated to the company. Remaining hedgies that are bullish include John Griffin’s Blue Ridge Capital, Samuel Isaly’s OrbiMed Advisors and William Leland Edwards’s Palo Alto Investors.

Due to the fact that BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has faced a declination in interest from hedge fund managers, we can see that there is a sect of hedgies that elected to cut their full holdings in Q4. Interestingly, Jacob Gottlieb’s Visium Asset Management cut the largest position of the 450+ funds we key on, valued at an estimated $42 million in stock., and Dan Loeb of Third Point was right behind this move, as the fund cut about $40 million worth. These bearish behaviors are interesting, as aggregate hedge fund interest fell by 9 funds in Q4.

What do corporate executives and insiders think about BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)?

Insider purchases made by high-level executives is best served when the company we’re looking at has experienced transactions within the past six months. Over the last 180-day time period, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has experienced 3 unique insiders purchasing, and 13 insider sales (see the details of insider trades here).

With the results exhibited by the aforementioned tactics, everyday investors must always watch hedge fund and insider trading activity, and BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is no exception.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!